Eli Lilly Says Court Blocks Generic Cymbalta
From the PharmaLive.com News Archive - Apr. 27, 2011
Eli Lilly and Co. said yesterday that a federal court is blocking
low-cost generic versions of Cymbalta from the market until the
patents supporting the drug expire. Eli Lilly said the order from the
court will stop generic competition for Cymbalta, Lilly's second
best-selling drug, until at least June 2013. Eli Lilly said the
litigation has been dismissed and no appeal is possible.
Powered by LSoft's LISTSERV(R) list management software